# Lifevantage Corp (LFVN)

> Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/lifevantage-corp/ JSON: https://steadybase.io/company/lifevantage-corp.json Checked Nov 10, 2026. Latest filing read: Sep 18, 2026.

## Company

- Legal name: Lifevantage Corp
- Ticker: LFVN (Nasdaq)
- SEC CIK: 0000849146
- Industry: Pharmaceutical Preparations (SIC 2834)
- Headquarters: Lehi, UT
- Fiscal year ends: December 31
- SEC filer category: Accelerated filer<br>Smaller reporting company
- Website: lifevantage.com
- LinkedIn: https://www.linkedin.com/company/lifevantage-corporation
- Next earnings date: Nov 9, 2026

## Key facts

- Revenue: $182.6M for the fiscal year ended Jun 30, 2026 (10-K filed Aug 27, 2026). Source: https://www.sec.gov/Archives/edgar/data/849146/000119312526371257/0001193125-26-371257-index.html
- Operating income: $6.1M for the fiscal year ended Jun 30, 2026 (10-K filed Aug 27, 2026). Source: https://www.sec.gov/Archives/edgar/data/849146/000119312526371257/0001193125-26-371257-index.html
- Net income: $5.1M for the fiscal year ended Jun 30, 2026 (10-K filed Aug 27, 2026). Source: https://www.sec.gov/Archives/edgar/data/849146/000119312526371257/0001193125-26-371257-index.html
- SG&A: $58.4M for the fiscal year ended Jun 30, 2026 (10-K filed Aug 27, 2026). Source: https://www.sec.gov/Archives/edgar/data/849146/000119312526371257/0001193125-26-371257-index.html
- Employees: 223 as of Jun 30, 2026, as reported in an SEC filing. Source: https://www.sec.gov/Archives/edgar/data/849146/000119312526371257/lfvn-20260630.htm
- Shares outstanding: 12,682,221 as of Nov 6, 2026 (10-Q filed Nov 9, 2026). Source: https://www.sec.gov/Archives/edgar/data/849146/000119312526453560/0001193125-26-453560-index.html
- Auditor: Deloitte & Touche LLP, Salt Lake City, Utah, named in the latest 10-K. Source: https://www.sec.gov/Archives/edgar/data/849146/000119312526371257/lfvn-20260630.htm

## Business

LifeVantage Corporation (the “Company,” “LifeVantage,” “we,” “us,” or “our”) is a company focused on nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. LifeVantage is dedicated to helping people achieve their health, wellness and financial goals. We provide quality, scientifically validated products to customers and independent consultants as well as a financially rewarding commission-based direct sales opportunity to our independent consultants.

Source: Item 1. Business, https://www.sec.gov/Archives/edgar/data/849146/000119312526371257/lfvn-20260630.htm

## Annual results

| Fiscal year ended | Revenue | Operating income | Net income | SG&A |
|---|---|---|---|---|
| Jun 30, 2026 | $182.6M | $6.1M | $5.1M | $58.4M |
| Jun 30, 2025 | $228.5M | $12.2M | $9.8M | $69.2M |
| Jun 30, 2024 | $200.2M | $4.3M | $2.9M | $68.5M |
| Jun 30, 2023 | $213.4M | $4.3M | $2.5M | $71.1M |
| Jun 30, 2022 | $206.4M | $7.6M | $3.1M | $63.4M |

Each figure comes from the annual report for that year. Filing links for every figure: https://steadybase.io/company/lifevantage-corp.json

## Officers and directors

- Terrence Moorehead, President and CEO. Source: Form 4 filed Aug 10, 2026, https://www.sec.gov/Archives/edgar/data/849146/000119312526342696/0001193125-26-342696-index.htm
- Carl Aure, Chief Financial Officer. LinkedIn: https://linkedin.com/in/carl-aure-946b2968. Source: Form 4 filed Sep 14, 2026, https://www.sec.gov/Archives/edgar/data/849146/000119312526390924/0001193125-26-390924-index.htm
- Kristen Cunningham, Chief Sales Officer. LinkedIn: https://linkedin.com/in/kristenbcunningham. Source: Form 4 filed Sep 14, 2026, https://www.sec.gov/Archives/edgar/data/849146/000119312526390923/0001193125-26-390923-index.htm
- Alissa Neufeld, General Counsel. LinkedIn: https://linkedin.com/in/alissa-neufeld. Source: Form 4 filed Jul 6, 2026, https://www.sec.gov/Archives/edgar/data/849146/000119312526296258/0001193125-26-296258-index.htm
- Todd Thompson, Chief Information Officer. Source: Form 4 filed Dec 29, 2025, https://www.sec.gov/Archives/edgar/data/849146/000162828025059057/0001628280-25-059057-index.htm
- Dayton Judd, Board member (per proxy). Source: DEF 14A filed Sep 18, 2026, https://www.sec.gov/Archives/edgar/data/849146/000119312526395513/lfvn-20260918.htm
- Michael Beindorff, Named in proxy. Source: DEF 14A filed Sep 18, 2026, https://www.sec.gov/Archives/edgar/data/849146/000119312526395513/lfvn-20260918.htm
- Cynthia Latham, Board member (per proxy). Source: DEF 14A filed Sep 19, 2025, https://www.sec.gov/Archives/edgar/data/849146/000162828025042171/lfvn-20250917.htm
- Darwin K. Lewis, Board member (per proxy). Source: DEF 14A filed Sep 19, 2025, https://www.sec.gov/Archives/edgar/data/849146/000162828025042171/lfvn-20250917.htm
- Julie Boyster, Named in proxy. Source: DEF 14A filed Sep 19, 2025, https://www.sec.gov/Archives/edgar/data/849146/000162828025042171/lfvn-20250917.htm
- Michael A. Beindorff, Board member (per proxy). Source: DEF 14A filed Sep 19, 2025, https://www.sec.gov/Archives/edgar/data/849146/000162828025042171/lfvn-20250917.htm
- Michelle Oborn, Named in proxy. Source: DEF 14A filed Sep 19, 2025, https://www.sec.gov/Archives/edgar/data/849146/000162828025042171/lfvn-20250917.htm
- Rajendran Anbalagan, Board member (per proxy). Source: DEF 14A filed Sep 19, 2025, https://www.sec.gov/Archives/edgar/data/849146/000162828025042171/lfvn-20250917.htm
- Raymond B. Greer, Board member (per proxy). Source: DEF 14A filed Sep 19, 2025, https://www.sec.gov/Archives/edgar/data/849146/000162828025042171/lfvn-20250917.htm

## Recent 8-K events

- Oct 5, 2026: Item 5.03, Amendments to articles or bylaws; change in fiscal year. Source: https://www.sec.gov/Archives/edgar/data/849146/000119312526414122/lfvn-20260929.htm
- Aug 27, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/849146/000119312526371265/lfvn-20260827.htm
- Aug 3, 2026: Item 5.02, Departure or appointment of directors or officers; compensation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/849146/000119312526330531/lfvn-20260731.htm
- May 6, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/849146/000119312526208934/lfvn-20260506.htm
- Apr 16, 2026: Item 5.02, Departure or appointment of directors or officers; compensation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/849146/000119312526159324/lfvn-20260413.htm
- Feb 4, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 5.02, Departure or appointment of directors or officers; compensation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/849146/000162828026005431/lfvn-20260130.htm
- Dec 9, 2025: Item 5.02, Departure or appointment of directors or officers; compensation. Source: https://www.sec.gov/Archives/edgar/data/849146/000162828025055939/lfvn-20251203.htm
- Nov 12, 2025: Item 5.07, Submission of matters to a vote of security holders. Source: https://www.sec.gov/Archives/edgar/data/849146/000162828025051641/lfvn-20251106.htm
- Nov 4, 2025: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/849146/000162828025048801/lfvn-20251104.htm
- Sep 4, 2025: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/849146/000084914625000069/lfvn-20250904.htm

## Insider trades (Form 4)

- Sep 15, 2026: Darwin Lewis (Director) bought 976 shares, about $6,071. Source: https://www.sec.gov/Archives/edgar/data/849146/000119312526394331/0001193125-26-394331-index.htm
- Sep 14, 2026: Kristen Cunningham (Chief Sales Officer) sold 9,001 shares, about $55,649. Source: https://www.sec.gov/Archives/edgar/data/849146/000119312526390923/0001193125-26-390923-index.htm
- Jun 15, 2026: Darwin Lewis (Director) bought 705 shares, about $6,063. Source: https://www.sec.gov/Archives/edgar/data/849146/000119312526274127/0001193125-26-274127-index.htm
- Jun 3, 2026: Michael A. Beindorff (Director) sold 10,000 shares, about $85,500. Source: https://www.sec.gov/Archives/edgar/data/849146/000119312526259533/0001193125-26-259533-index.htm
- Mar 16, 2026: Darwin Lewis (Director) bought 1,055 shares, about $5,518. Source: https://www.sec.gov/Archives/edgar/data/849146/000119312526114085/0001193125-26-114085-index.htm
- Mar 2, 2026: Judd Dayton (Director) bought 33,197 shares, about $152,422. Source: https://www.sec.gov/Archives/edgar/data/849146/000162828026013462/0001628280-26-013462-index.htm
- Feb 9, 2026: Darwin Lewis (Director) bought 3,955 shares, about $20,645. Source: https://www.sec.gov/Archives/edgar/data/849146/000162828026007303/0001628280-26-007303-index.htm
- Dec 15, 2025: Darwin Lewis (Director) bought 805 shares, about $5,265. Source: https://www.sec.gov/Archives/edgar/data/849146/000162828025057657/0001628280-25-057657-index.htm
- Nov 19, 2025: Michael A. Beindorff (Director) sold 12,607 shares, about $80,937. Source: https://www.sec.gov/Archives/edgar/data/849146/000162828025053629/0001628280-25-053629-index.htm
- Nov 7, 2025: Michael A. Beindorff (Director) sold 36,000 shares, about $249,530. Source: https://www.sec.gov/Archives/edgar/data/849146/000162828025051221/0001628280-25-051221-index.htm
- Sep 16, 2025: Darwin Lewis (Director) bought 450 shares, about $4,883. Source: https://www.sec.gov/Archives/edgar/data/849146/000169876725000003/0001698767-25-000003-index.htm
- Sep 9, 2025: Michael A. Beindorff (Director) sold 4,325 shares, about $49,460. Source: https://www.sec.gov/Archives/edgar/data/849146/000162828025041954/0001628280-25-041954-index.htm
- Jul 1, 2025: Carl Aure (Chief Financial Officer) sold 2,746 shares, about $36,769. Source: https://www.sec.gov/Archives/edgar/data/849146/000084914625000056/0000849146-25-000056-index.htm

## What management said

- "Despite a challenging quarter, LifeVantage has significant untapped potential, and we now have a clear strategy designed to capture it" Terrence Moorehead, President and Chief Executive Officer (8-K filed Nov 9, 2026). Source: https://www.sec.gov/Archives/edgar/data/849146/000119312526453570/lfvn-ex99_1.htm
- "It's a privilege to lead LifeVantage at this stage of its journey and my conviction about this Company is stronger today than when I accepted the role" Terrence Moorehead, President and Chief Executive Officer (8-K filed Aug 27, 2026). Source: https://www.sec.gov/Archives/edgar/data/849146/000119312526371265/lfvn-ex99_1.htm

## Latest filings

- 8-K filed Oct 5, 2026: https://www.sec.gov/Archives/edgar/data/849146/000119312526414122/lfvn-20260929.htm
- 10-K filed Aug 27, 2026: https://www.sec.gov/Archives/edgar/data/849146/000119312526371257/lfvn-20260630.htm
- 10-Q filed May 6, 2026: https://www.sec.gov/Archives/edgar/data/849146/000119312526208922/lfvn-20260331.htm
- DEF 14A filed Sep 18, 2026: https://www.sec.gov/Archives/edgar/data/849146/000119312526395513/lfvn-20260918.htm

## About this data

SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from.
Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/